230 related articles for article (PubMed ID: 21625978)
61. Immediate-Early (IE) gene regulation of cytomegalovirus: IE1- and pp71-mediated viral strategies against cellular defenses.
Torres L; Tang Q
Virol Sin; 2014 Dec; 29(6):343-52. PubMed ID: 25501994
[TBL] [Abstract][Full Text] [Related]
62. Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.
Young VP; Mariano MC; Tu CC; Allaire KM; Avdic S; Slobedman B; Spencer JV
J Infect Dis; 2017 Mar; 215(6):874-882. PubMed ID: 28453840
[TBL] [Abstract][Full Text] [Related]
63. Human cytomegalovirus-encoded MicroRNAs: A master regulator of latent infection.
Abdalla AE; Mahjoob MO; Abosalif KOA; Ejaz H; Alameen AAM; Elsaman T
Infect Genet Evol; 2020 Mar; 78():104119. PubMed ID: 31740397
[TBL] [Abstract][Full Text] [Related]
64. Polycomb repressive complex 2 silences human cytomegalovirus transcription in quiescent infection models.
Abraham CG; Kulesza CA
J Virol; 2013 Dec; 87(24):13193-205. PubMed ID: 24067968
[TBL] [Abstract][Full Text] [Related]
65. The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency.
Cheung AK; Gottlieb DJ; Plachter B; Pepperl-Klindworth S; Avdic S; Cunningham AL; Abendroth A; Slobedman B
Blood; 2009 Nov; 114(19):4128-37. PubMed ID: 19706889
[TBL] [Abstract][Full Text] [Related]
66. Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
Mach M; Kropff B; Dal Monte P; Britt W
J Virol; 2000 Dec; 74(24):11881-92. PubMed ID: 11090188
[TBL] [Abstract][Full Text] [Related]
67. Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis.
Ripalti A; Landini MP; Mocarski ES; La Placa M
J Gen Virol; 1989 May; 70 ( Pt 5)():1247-51. PubMed ID: 2543778
[TBL] [Abstract][Full Text] [Related]
68. Epitope analysis of antibodies in Japanese to human cytomegalovirus phosphoprotein 150 with synthetic peptides.
Takahashi I; Sugiura S; Ohta H; Ozawa K; Kamiya T
Biosci Biotechnol Biochem; 2002 Nov; 66(11):2402-5. PubMed ID: 12506979
[TBL] [Abstract][Full Text] [Related]
69. Human Cytomegalovirus Reactivation During Lactation: Impact of Antibody Kinetics and Neutralization in Blood and Breast Milk.
Lazar K; Rabe T; Goelz R; Hamprecht K
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32012818
[TBL] [Abstract][Full Text] [Related]
70. Human cytomegalovirus persistence.
Goodrum F; Caviness K; Zagallo P
Cell Microbiol; 2012 May; 14(5):644-55. PubMed ID: 22329758
[TBL] [Abstract][Full Text] [Related]
71. Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system.
Söderberg-Nauclér C; Nelson JY
Intervirology; 1999; 42(5-6):314-21. PubMed ID: 10702712
[TBL] [Abstract][Full Text] [Related]
72. Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls.
Mohammad AA; Rahbar A; Lui WO; Davoudi B; Catrina A; Stragliotto G; Mellbin L; Hamsten A; Rydén L; Yaiw KC; Söderberg-Nauclér C
PLoS One; 2014; 9(12):e113740. PubMed ID: 25462570
[TBL] [Abstract][Full Text] [Related]
73. Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150.
Plachter B; Wieczorek L; Scholl BC; Ziegelmaier R; Jahn G
J Clin Microbiol; 1992 Jan; 30(1):201-6. PubMed ID: 1310328
[TBL] [Abstract][Full Text] [Related]
74. [Cytomegalovirus (CMV)].
Kosugi I
Uirusu; 2010 Dec; 60(2):209-20. PubMed ID: 21488334
[TBL] [Abstract][Full Text] [Related]
75. PCR activity of CMV in healthy CMV-seropositive individuals: does latency need redefinition?
Toro AI; Ossa J
Res Virol; 1996; 147(4):233-8. PubMed ID: 8837231
[TBL] [Abstract][Full Text] [Related]
76. Cytomegalovirus and the aging population.
Emery VC
Drugs Aging; 2001; 18(12):927-33. PubMed ID: 11888347
[TBL] [Abstract][Full Text] [Related]
77. A Virally Encoded DeSUMOylase Activity Is Required for Cytomegalovirus Reactivation from Latency.
Poole EL; Kew VG; Lau JCH; Murray MJ; Stamminger T; Sinclair JH; Reeves MB
Cell Rep; 2018 Jul; 24(3):594-606. PubMed ID: 30021158
[TBL] [Abstract][Full Text] [Related]
78. Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection.
Weekes MP; Tan SY; Poole E; Talbot S; Antrobus R; Smith DL; Montag C; Gygi SP; Sinclair JH; Lehner PJ
Science; 2013 Apr; 340(6129):199-202. PubMed ID: 23580527
[TBL] [Abstract][Full Text] [Related]
79. US28: HCMV's Swiss Army Knife.
Krishna BA; Miller WE; O'Connor CM
Viruses; 2018 Aug; 10(8):. PubMed ID: 30127279
[No Abstract] [Full Text] [Related]
80. Human cytomegalovirus encodes a highly specific RANTES decoy receptor.
Wang D; Bresnahan W; Shenk T
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16642-7. PubMed ID: 15536129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
